Skip to main content
SpringerLink
Log in

International nifedipine trial on anti-atherosclerotic therapy (INTACT) — methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis

  • Published:
The International Journal of Cardiac Imaging Aims and scope Submit manuscript

Abstract

Animal experiments demonstrated a significant suppressive effect of various calcium channel blockers on the formation of atherosclerotic lesions. Therefore, a prospective, placebo-controlled, randomized, double blind multicenter study was performed to investigate the inhibitory influence of the calcium channel blocker nifedipine (80 mg/day) on the progression of coronary artery disease in man. Study endpoints were changes of coronary morphology documented by coronary angiography with particular respect to the formation of new coronary stenoses. In 348 out of 425 patients included in the study, coronary angiograms were repeated after three years. The angiograms were standardized by induction of a maximal coronary vasodilation with high doses of nitrates and by using absolutely identical angiographic projections. Quantitative analysis of coronary cineangiograms was performed with the computer-assisted contour detection system CAAS. Parameters were mean and minimal diameter of all segments and minimal stenosis diameter, percent diameter stenosis, length and plaque area of all stenoses.

Continuous intake of study medication was registered in 282 patients, 134 on nifedipine and 148 patients on placebo. In these patients, a total of 3808 coronary segments with 893 stenoses (⩾ 20% diameter reduction in at least one angiographic projection) were compared on the baseline and follow-up cineangiograms. The changes in all angiographic parameters analyzed averaged over all patients by considering all angiographic projections analyzed, indicated significant progression of the disease (p < 0.006). The average changes in all parameters were even about three times more profound, when in the individual patients only the respective projections indicating the maximal changes were considered for the calculation (p < 0.001). However, with neither of these two analysis modes, the differences in progression between the treatment groups were statistically significant.

In the follow-up angiograms, a total of 196 new coronary lesions (185 stenoses, 11 occlusions) were found at previously normal arterial sites. In patients on nifedipine, an average of only 0.58 new lesions per patient were detected versus 0,80 lesions per patient on placebo (−27%; p=0.031).

INTACT is the first prospective angiographic trial on the progression of coronary artery disease using computer-assisted quantitative coronary angiography in such a high number of patients. All parameters analyzed indicated significant progression of coronary artery sclerosis. Nifedipine had no influence on the progression of preexisting coronary stenoses, but inhibited significantly the formation of new angiographically recognizable lesions. Further prospective coronary angiographic trials with calcium channel blockers using a comparably exact method are needed to confirm the results of this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. The Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA 1975; 231: 360–81.

    Article  Google Scholar 

  2. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. JAMA 1982; 248: 1546–77.

    Google Scholar 

  3. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results. JAMA 1984; 251: 351–64.

    Article  Google Scholar 

  4. Kromhout D, Bosschieter EB, Lezenne Coulander C. The inverse relation between fish consumption and 20 year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205–9.

    Article  CAS  PubMed  Google Scholar 

  5. Kushi LH, Lew RA, Stare FJ, Ellisson CR, El Lozy M, Bourke G, Daly L, Graham I, Hiday N, Mulcahy R, Kevaney R. Diet and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 811–8.

    Article  CAS  PubMed  Google Scholar 

  6. Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: The lipid research clinics coronary primary prevention trial. Circulation 1986; 6: 1217–25.

    Google Scholar 

  7. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality; 30 years of follow-up from the Framingham study. JAMA 1987; 257:2176–80.

    Article  CAS  PubMed  Google Scholar 

  8. Frick MH, Elo O, Haapak M, Heinonen OP et al. Helsinki heart study: primary-prevention trial with Gemfibrozil in middle aged men with dyslipidemia. N Engl J Med 1987; 317: 1237–45.

    Article  CAS  PubMed  Google Scholar 

  9. Abbott RD, Wilson PWF, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. Arteriosclerosis 1988; 8: 207–11.

    CAS  PubMed  Google Scholar 

  10. Nash DT, Gensini G, Simon H, Arno T, Nash SD. The Erysichthon syndrome; progression of coronary atherosclerosis and dietary hyperlipidemia. Circulation 1977; 56: 363–5.

    CAS  PubMed  Google Scholar 

  11. Rafflenbeul W, Smith LR, Rogers WJ, Mantle JA, Rackley LE, Russel RO. Quantitative coronary angiography: coronary anatomy of unstable angina pectoris one year after optimal medical therapy. Am J Cardiol 1979; 43: 699–707.

    Article  CAS  PubMed  Google Scholar 

  12. Brensike JF, Levy RI, Kelsey SF et al. Effects of therapy with cholestyramine on progression of coronary atherosclerosis: results of the NHLBI-type II coronary intervention study. Circulation 1984; 69: 313–24.

    CAS  PubMed  Google Scholar 

  13. Levy RI, Brensike JF, Epstein STE. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI-type II coronary intervention study. Circulation 1984; 69: 325–36.

    CAS  PubMed  Google Scholar 

  14. Arntzenius AC, Kromhout D, Barth JD, Reiber JHC, Bruschke AVG, Buis B, van Gent CM, Kempen-Voogd N, Strikwerda S, van der Velde EA. Diet, lipoproteins and the progression of coronary atherosclerosis. The Leiden interventional trial. N Engl J Med 1985; 312: 805–11.

    Article  CAS  PubMed  Google Scholar 

  15. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cahin Hemphill LC. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233–40.

    Article  CAS  PubMed  Google Scholar 

  16. Brown BG, Lin JT, Schaefer SM, Kaplan CA, Dodge HT, Albers JJ. Niacin or lovastatin, combined with colestipol, regress coronary atherosclerosis and prevent clinical events in men with elevated apolipoprotein B. Circulation 1989; 4: II266 (Abstract).

  17. Waters D, Lespérance J, Francetich M, Causey D, Théroux P, Chiang YK, Hudon G, Lemarbre L, Reitman M, Joyal M, Gosselin G, Dyrda I, Macer J, Havel R. A controlled clinical trial to assess the effect of a calcium channel blocker upon the progression of coronary atherosclerosis. Circulation 1990; 82: 1940–53.

    CAS  PubMed  Google Scholar 

  18. Detre KM, Wright E, Murphy ML, Takaro T. Observer agreement in evaluating coronary angiograms. Circulation 1975; 52: 979–86.

    CAS  PubMed  Google Scholar 

  19. Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW. Interobserver variability in coronary angiography. Circulation 1976; 53: 627–32.

    CAS  PubMed  Google Scholar 

  20. Galbraith JE, Murphy ML, de Soyza N. Coronary angiogram interpretation. JAMA 1978; 19: 2053–6.

    Article  Google Scholar 

  21. Sanmarco ME, Brooks SH, Blankenhorn DH. Reproducibility of a consensus panel in the interpretation of coronary angiograms. Am Heart J 1978; 96: 430–7.

    Article  CAS  PubMed  Google Scholar 

  22. Brown BG, Bolson E, Frimer M, Dodge HT. Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation. Circulation 1977; 55: 329–37.

    CAS  PubMed  Google Scholar 

  23. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JCH, den Boer A, Hugenholtz PG. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985; 71: 280–8.

    CAS  PubMed  Google Scholar 

  24. Reiber JHC. Morphologic and densitometric quantitation of coronary stenoses; an overview of existing quantitation techniques. In: Reiber JHC, Serruys PW, eds. New developments in quantitative coronary arteriography. Kluwer Academic Publishers, Dordrecht, Boston, London. 1988: 34–88.

    Google Scholar 

  25. Reiber JHC, van Eldik-Helleman P, Visser-Akkerman N, Kooijman CJ, Serruys PW. Variabilities in measurement of coronary arterial dimensions resulting from variations in cineframe selection. Cathet Cardiovasc Diagn 1988; 14: 221–8.

    CAS  PubMed  Google Scholar 

  26. Reiber JHC, den Boer A, Serruys PW. Quality control in performing quantitative coronary arteriographic studies. Am J Cardiac Imaging 1989; 172–179.

  27. Henry PD, Bentley K. Suppression of atherosclerosis in cholesterol-fed rabbits treated with nifedipine. J Clin Invest 1981; 68: 1366–9.

    Article  CAS  PubMed  Google Scholar 

  28. Rouleau JL, Parmley WW, Stevens J, Wikman-Coffelt J, Sievers R, Mahley RW, Havel RJ. Verapamil suppresses atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 1983; 6: 1453–60.

    Google Scholar 

  29. Willis AL, Nagel B, Churchill V, Whyte MA, Smith DL, Mahmud I, Puppione DL. Anti-atherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits. Arteriosclerosis 1985; 5: 250–5.

    CAS  PubMed  Google Scholar 

  30. Nayler WG, Dillon JS, Panagiotopoulos S, Sturrock WJ. Dihydropyridines and the ischaemic myocardium. In: Lichtlen PR, ed., 6th Adalat Symposium. New Therapy of Ischemic Heart Disease and Hypertension. Amsterdam. Excerpta Medica 1986: 386–97.

  31. Lichtlen PR, Nellessen U, Rafflenbeul W, Jost S, Hecker H. INTACT (International Nifedipine Trial on Antiatherosclerotic Therapy). Cardiovasc Drugs Ther 1987; 1: 71–9.

    Article  CAS  PubMed  Google Scholar 

  32. Jost S, Deckers J, Nellessen U, Rafflenbeul W, Hecker H, Reiber JHC, Hugenholtz PG, Lichtlen PR. Clinical application of quantitative coronary angiography — preliminary results of the INTACT-study (International Nifedipine Trial on Antiatherosclerotic Therapy). Int J Cardiac Imaging 1988; 3: 75–86.

    Article  CAS  Google Scholar 

  33. Jost S, Deckers J, Nellessen U, Rafflenbaul W, Hecker H, Reiber JHC, Lippolt P, Hugenholtz PG, Lichtlen PR. Computer-assisted contour analysis technique in coronary angiographic follow-up trials: results of the first angiograms from the INTACT-study. Z Kardiol 1989; 78: 23–32.

    CAS  PubMed  Google Scholar 

  34. Lichtlen PR, Hugenholtz PG, Jost S. International nifedipine trial on antiatherosclerotic therapy (INTACT) — baseline data and preliminary results. Therap Res 1989; 10: 77–102.

    Google Scholar 

  35. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW. Retardation of the angiographic progression of coronary artery disease in man by the calcium channel blocker nifedipine — results of the international nifedipine trial on antiatherosclerotic therapy (INTACT). The Lancet 1990; 335: 1109–13.

    Article  CAS  Google Scholar 

  36. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Nikutta P, Deckers W. Retardation of the progression of coronary artery disease in man by nifedipine; the INTACT-study (International Nifedipine Trial on Antiatherosclerotic Therapy). Cardiovasc Drugs Ther 1990; 4: 1047–68.

    Article  PubMed  Google Scholar 

  37. Jost S, Rafflenbeul W, Reil GH, Gulba D, Knop I, Hecker H, Lichtlen PR. Reproducible uniform coronary vasomotor tone with nitrocompounds: Prerequisite of quantitative coronary angiographic trials. Cathet Cardiovasc Diagn 1990; 20: 168–73.

    CAS  PubMed  Google Scholar 

  38. Jost S, Deckers J, Rafflenbeul W, Hecker H, Nellessen U, Wiese B, Hugenholtz PG, Lichtlen PR. Features of the angiographic evaluation of the INTACT-study. Cardiovasc Drugs Ther 1990; 4: 1037–46.

    Article  PubMed  Google Scholar 

  39. Austen WG, Edwards JE, Frye RL, Gensini G, Gott VL, Griffith LSC, McGoon DG, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease: report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: 5–40.

    CAS  PubMed  Google Scholar 

  40. Christensen EE, Curry IS III, Dowdey JE. An introduction to the physics of diagnostic radiology, 2nd ed. Philadelphia: Lea and Febiger, 1978: 158–70.

    Google Scholar 

  41. Arnett EN, Isner JM, Redwood DR, Kent KM, Baker WP, Ackerstein H, Roberts WC. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Annals Intern Med 1979; 91: 350–6.

    CAS  Google Scholar 

  42. Rösch J, Antonovic R, Trenouth RS, Rahimtoola SH, Sim DN, Dotter CT. The natural history of coronary artery stenosis. Radiology 1976; 119: 513–20.

    PubMed  Google Scholar 

  43. Bruschke AVG, Wijers TS, Kolsters W, Landmann J. The anatomic evaluation of coronary artery disease demonstrated by coronary angiography in 256 nonoperated patients. Circulation 1981; 63: 527–30.

    CAS  PubMed  Google Scholar 

  44. Kramer JR, Kitazume H, Proudfit WL, Matsuda Y, Coormastic M, Williams GW, Sones FM. Segmental analysis of the rate of progression in patients with progressive coronary atherosclerosis. Am Heart J 1983; 106: 1427–31.

    Article  CAS  PubMed  Google Scholar 

  45. Olinger GN, Mulder DG, Maloney JV, Buckberg GD. Phasic coronary flow: intraoperative evaluation of flow distribution, myocardial function, and reactive hyperemic response. Ann Thoracic Surg 1976; 21: 397–404.

    Article  CAS  Google Scholar 

  46. Schettler G, Nerem RM, Schmid-Schönbein H, Mörl H, Diehm C, eds. Fluid dynamics as a localizing factor for atherosclerosis. Springer-Verlag, Heidelberg, 1983: 1–226.

    Google Scholar 

  47. Loaldi A, Polese A, Montorsi P, De Cesare N, Fabbiocchi F, Ravagnani P, Guazzi MD. Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris. Am J Cardiol 1989; 64: 433–9.

    Article  CAS  PubMed  Google Scholar 

  48. Cohn K, Sakai FJ, Langston MF. Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man. Am Heart J 1975; 89: 591–8.

    Article  CAS  PubMed  Google Scholar 

  49. Kuo PT, Hayase K, Kostis JB, Moreyra AE. Use of combined diet and colestipol in long-term (7–7½; years) treatment of patients with type II hyperlipoproteinemia. Circulation 1979; 2: 199–214.

    Google Scholar 

  50. Kramer JR, Matsuda Y, Mulligan JC, Aronow M, Proudfit WL. Progression of coronary atherosclerosis. Circulation 1981; 3: 519–26.

    Google Scholar 

  51. Nash DT, Gensini G, Esente P. Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography. Intern J Cardiol 1982; 2: 43–55.

    Article  CAS  Google Scholar 

  52. Moise A, Théroux P, Taeymans J, Waters DD, Lespérance J, Fines P, Descoings B, Robert P. Clinical and angiographic factors associated with progression of coronary artery disease. J Am Coll Cardiol 1984; 3: 659–67.

    Article  CAS  PubMed  Google Scholar 

  53. Nikkilä EA, Viikinkoski P, Valle M, Frick MH. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. Br Med J 1984; 289: 220–3.

    Article  Google Scholar 

  54. Ross R. The pathogenesis of atherosclerosis — an update. N Engl J Med 1986; 8: 488–500.

    Article  Google Scholar 

  55. Folts JD, Gallagher K, Rowe GG. Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation 1982; 65: 248–55.

    CAS  PubMed  Google Scholar 

  56. Davies MJ, Thomas AC. Plaque fissuring — the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985; 53: 363–73.

    CAS  PubMed  Google Scholar 

  57. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985; 71: 699–708.

    CAS  PubMed  Google Scholar 

  58. Ellis S, Sanders W, Goulet C, Miller R, Cain KC, Lespérance J, Bourassa MG, Alderman EL. Optimal detection of the progression of coronary artery disease: comparison of methods suitable for risk factor intervention trials. Circulation 1986; 74: 1235–46.

    CAS  PubMed  Google Scholar 

  59. Gensini GG, Kelly AE. Incidence and progression of coronary artery disease. Arch Intern Med 1972; 129: 814–27.

    Article  CAS  PubMed  Google Scholar 

  60. Shub C, Vlietstra RE, Smith HC, Fulton RE, Elveback L. The unpredictable progression of symptomatic coronary artery disease. Mayo Clin Proc 1981; 56: 155–60.

    CAS  PubMed  Google Scholar 

  61. Spears JR, Sandor T, Baim BS, Paulin S. The minimum error in estimating coronary luminal cross sectional area from cineangiographic diameter measurements. Cathet Cardiovasc Diagn 1986; 9: 119–32.

    Google Scholar 

  62. Serruys PW, Reiber JHC, Wijns W, van den Brand M, Kooijman CJ, ten Katen HJ, Hugenholtz PG. Assessment of percutaneous transluminal coronary angioplasty by quantitative coronary angiography: diameter versus densitometric area measurements. Am J Cardiol 1984; 54: 482–8.

    Article  CAS  PubMed  Google Scholar 

  63. Seibert JA, Nalcioglu O, Roeck WW. Characterization of the veiling glare PSF in x-ray image intensified fluoroscopy. Med Phys 1984; 11: 172–9.

    Article  CAS  PubMed  Google Scholar 

  64. Barrett W, Boone J. The effect of beam hardening and scatter on videodensitometric determination of percent stenosis. IEEE 1985: 15–20.

  65. Sanz ML, Mancini J, LeFree MT, Mickelsen JK, Starling MR, Vogel RA, Topol EJ. Variability of quantitative digital subtraction coronary angiography before and after percutaneous transluminal coronary angioplasty. Am J Cardiol 1987; 60: 55–60.

    Article  CAS  PubMed  Google Scholar 

  66. Katritsis D, Lythall DA, Anderson MH, Cooper IC, Klebb-Peploe MM. Assessment of coronary angioplasty by an automated digital angiographic method. Am Heart J 1988; 116: 1181–7.

    Article  CAS  PubMed  Google Scholar 

  67. Roth D, Kostuk WJ. Noninvasive and invasive demonstration of spontaneous regression of coronary artery disease. Circulation 1980; 62: 888–96.

    CAS  PubMed  Google Scholar 

  68. Malinow MR, Blaton V. Regression of atherosclerotic lesions. Arteriosclerosis 1984; 4: 292–5.

    CAS  PubMed  Google Scholar 

  69. Shepherd J, Packard CJ. Regression of coronary atherosclerosis: is it possible? Br Heart J 1988; 59: 149–50.

    CAS  PubMed  Google Scholar 

  70. Blankenhorn DH, Kramsch DM. Reversal of atherosis and sclerosis; the two components of atherosclerosis. Circulation 1989; 79: 1–7.

    CAS  PubMed  Google Scholar 

  71. Freudenberg H, Knieriem H-J, Möller C, Janzen C. Quantitative morphology of coronary arteriosclerosis and coronary insufficiency. Basic Res Cardiol 1974; 69: 161–203.

    Article  CAS  PubMed  Google Scholar 

  72. Isner JM, Donaldson RF, Fortin AH, Tischler A, Clarke RH. Attenuation of the media of coronary arteries in advanced atherosclerosis. Am J Cardiol 1986; 937–9.

  73. Glagov S, Weisenberg E, Zarins C, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371–5.

    Article  CAS  PubMed  Google Scholar 

  74. McPherson DD, Hiratzka LF, Lamberth WC, Brandt B, Hunt M, Gieso RA, Marcus ML, Kerber RE. Delineation of the extent of coronary atherosclerosis by high-frequency epicardial echocardiography. N Engl J Med 1987; 316: 304–9.

    Article  CAS  PubMed  Google Scholar 

  75. Johnson MR, McPherson DD, Fleagle SR, Hunt MM, Hiratzka LF, Kerber RE, Marcus ML, Collins SM, Skorton DJ. Videodensitometric analysis of human coronary stenoses: validationin vivo by intraoperative high-frequency epicardial echocardiography. Circulation 1988; 77: 328–36.

    CAS  PubMed  Google Scholar 

  76. Magnetic resonance and revival of arterial sclerosis (editorial). The Lancet 1990; 350: 139–40.

    Google Scholar 

  77. Le Free MT, Simon SB, Lewis RJ, Bates ER, Vogel RA. Digital radiographic coronary artery quantification. Comput Cardiol 1985: 99–106.

  78. Mancini BJ, Higgins CHB. Digital subtraction angiography: a review of cardiac applications. Progr Cardiovasc Dis 1985; 28: 111–41.

    Article  CAS  Google Scholar 

  79. Jost S, Rafflenbeul W, Lichtlen PR. Assessment of the vasomotility of epicardial coronary arteries with quantitative coronary angiography. Z Kardiol 1989; 78: Suppl 6, 143–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Hannover Medical School, Hannover, Germany

    Stefan Jost, Jaap Deckers, Wolf Rafflenbeul, Hartmut Hecker, Johan H. C. Reiber, Peter Nikutta, Birgitt Wiese, Paul Hugenholtz & Paul Lichtlen

  2. Thorax Center, Erasmus University, Rotterdam, The Netherlands

    Jaap Deckers, Johan H. C. Reiber & Paul Hugenholtz

Authors
  1. Stefan Jost
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaap Deckers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wolf Rafflenbeul
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hartmut Hecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Johan H. C. Reiber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter Nikutta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Birgitt Wiese
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Paul Hugenholtz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Paul Lichtlen
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the INTACT-Group

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jost, S., Deckers, J., Rafflenbeul, W. et al. International nifedipine trial on anti-atherosclerotic therapy (INTACT) — methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis. Int J Cardiac Imag 6, 117–133 (1990). https://doi.org/10.1007/BF02398895

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02398895

Key words

Search

Navigation